Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M M Bosca-Watts"'
Autor:
M Calafat Sard, C Súria, F Mesonero, R de Francisco, C Yagüe Caballero, L de la Peña, A Hernández-Camba, A Marcè, B Gallego, N Martín-Vicente, M Rivero, M Iborra, I Guerra, M Carrillo-Palau, L Madero, B Burgueño, D Montfort, G Torres, M Teller, J Á Ferrer Rosique, P Vega Villaamil, C Roig, Á Ponferrada, E Betoré Glaría, Y Zabana, J P Gisbert, N Alcaide, B Camps, J Legido, M González Vivo, M M Bosca-Watts, I Pérez-Martínez, D Casas Deza, J Guardiola, L Arranz Hernández, M Navarro, F Gomollon, F Cañete, M Mañosa, E Domènech
Publikováno v:
Journal of Crohn's and Colitis. 17:i80-i81
Background The coexistence of immune-mediated diseases and non-pharmacological immunosuppression states are rare and might determine the natural history of the disease and therapeutic decisions of the physician. IBD guidelines recommend screening for
Autor:
Dederichs, Frank1 (AUTHOR) F.Dederichs@kkh-Hagen.de, Iesalnieks, Igor2 (AUTHOR), Sladek, Malgrozata3 (AUTHOR), Tzivinikos, Christos4 (AUTHOR), Hansen, Richard5 (AUTHOR), Muñoz, Carmen6 (AUTHOR), Pavli, Paul7 (AUTHOR), Cavicchi, Mayran8 (AUTHOR), Abitbol, Vered9 (AUTHOR), Rahier, Jean-Francois10 (AUTHOR), Vavricka, Stephan11 (AUTHOR), Katsanos, Konstantinos12 (AUTHOR), Domènech, Eugeni13 (AUTHOR), investigators, ECCO-CONFER (AUTHOR)
Publikováno v:
Journal of Crohn's & Colitis. Feb2018, Vol. 12 Issue 2, p197-203. 7p.
Publikováno v:
Alimentary Pharmacology & Therapeutics. Nov2018, Vol. 48 Issue 9, p889-891. 3p.
Autor:
Weaver, Kimberly N., Herfarth, Hans
Publikováno v:
Molecular Nutrition & Food Research; Mar2021, Vol. 65 Issue 5, p1-7, 7p
Autor:
Ballester, M. P., Marti-Aguado, D., Bosca-Watts, M. M., Tosca, J., Romero, E., Sanchez, A., Navarro-Cortes, P., Anton, R., Mora, F., Minguez, M., Fullana, M.
Publikováno v:
International Journal of Colorectal Disease; Jun2019, Vol. 34 Issue 6, p1053-1059, 7p, 1 Diagram, 2 Charts, 2 Graphs
Publikováno v:
Medical Devices & Surgical Technology Week; 2/18/2024, p885-885, 1p
Publikováno v:
Medical Devices & Surgical Technology Week; 2/18/2024, p853-853, 1p
Publikováno v:
Immunotherapy Weekly; 2/15/2024, p2704-2704, 1p
Autor:
Gionata Fiorino, Alessandro Armuzzi, Federica Furfaro, M Silva, Giovanni Maconi, Fabrizio Bossa, Carla Felice, P Karatzas, Gerassimos J. Mantzaris, Martina Muscat, Shomron Ben-Horin, PN Cortes, Bella Ungar, Shaji Sebastian, Uri Kopylov, Silvio Danese, Konstantinos Karmiris, M Boscá-Watts, Fernando Magro, Konstantinos H. Katsanos, Dimitrios K. Christodoulou, Stefanos Bonovas, Pierre Ellul, Péter Lakatos
Publikováno v:
Gut. 65:A88-A89
Introduction Efficacy and safety of infliximab in ulcerative colitis (UC) is well-established. We conducted a multicenter retrospective cohort study across 7 European countries, and Israel, to examine whether infliximab discontinuation can be conside